ABIOMED

$301.22
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$5.59 (+1.89%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell ABIOMED and other stocks, options, and ETFs commission-free!

About ABMD

ABIOMED, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It distributes its products under the Impella brand. The company was founded by David M. Lederman in 1981 and is headquartered in Danvers, MA. The listed name for ABMD is ABIOMED, Inc. Common Stock.

CEO
Michael R. Minogue
Employees
1,536
Headquarters
Danvers, Massachusetts
Founded
1981
Market Cap
14.18B
Price-Earnings Ratio
68.57
Dividend Yield
—
Average Volume
305.40K
High Today
$302.57
Low Today
$281.00
Open Price
$297.24
Volume
407.22K
52 Week High
$387.40
52 Week Low
$119.01

ABMD News

MarketWatchMar 5

Abiomed Inc. stock rises Friday, still underperforms market

Shares of Abiomed Inc. ABMD, +1.89% rallied 1.89% to $301.22 Friday, on what proved to be an all-around positive trading session for the stock market, with the

ABMD Earnings

$0.00
$0.45
$0.90
$1.35
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Apr 29, Pre-Market

You May Also Like

KIM-L
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure